Serum proteomics guided discovery of predictive biomarkers of response to androgen ablation (AA) in prostate cancer.
Manish Kohli(Mayo Clinic in Arizona), Sheng Zhang(Nanchang University), Douglas W. Mahoney, Roman M. Zenka(Mayo Clinic in Florida), Ann L. Oberg(University of Minnesota), Deepak M. Sahasrabudhe(University of Rochester Medical Center), Shaun M. Riska(Mayo Clinic in Florida)
Cited by 1
Related Papers
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
|New England Journal of Medicine|2015|2.8k
Sirt5 Is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase
|Science|2011|1.4k
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial
|Journal of Clinical Oncology|2018|1.1k